Alzheimer’s group launches tool to connect patients with health resources
An organization advocating for a cure for Alzheimer’s rolled out a new tool Wednesday that’s designed to evaluate individuals and connect them with health resources.
BrainGuide, a platform launched by UsAgainstAlzheimer’s, will allow users to take a memory questionnaire to check for signs of the disease that affects more than 6 million Americans and then connect them with health and educational resources based on their answers.
Brooks Kenny, general manager of BrainGuide, said the tool can provide relevant information to those who are trying to improve their brain health, concerned about their memory, seeking more information after a diagnosis or taking care of someone else with the disease.
On a call with reporters, Kenny said the organization did not need to seek regulatory approval since the platform is not formally diagnosing patients.
Alzheimer’s is the sixth leading cause of death among U.S. adults, according to the Centers for Disease Control and Prevention (CDC).
Russ Paulsen, chief operating officer of UsAgainstAlzheimer’s, said despite its prevalence in the U.S., the disease is still not understood well enough by most Americans.
He added that the disease is not just a health concern but a health equity issue as well. The disease is most prevalent among African Americans and Hispanics, and those numbers are expected to increase in the coming decades, according to the CDC.
An increase in Alzheimer’s patients is likely to put a strain on health care providers.
On Capitol Hill, a bill introduced in January by Sen. Amy Klobuchar (D-Minn.) would authorize the Department of Health and Human Services to award grants for public and nonprofit health care providers to expand training and support for Alzheimer’s patient caregivers.
The bill, which has two co-sponsors, has been referred to the Senate Health, Education, Labor and Pensions Committee.
The Hill has removed its comment section, as there are many other forums for readers to participate in the conversation. We invite you to join the discussion on Facebook and Twitter.